RxDoctor Payments Data

Shekar Narayanan, MD

Colon & Rectal Surgery · Indianapolis, INNPI 1881763977

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $53,446 of the $66,934 with a category attached, or 79.8%. Johnson & Johnson accounts for 61.9% of it on its own, with 32 other manufacturers making up the rest. Among colon & rectal surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,934in general payments, 2019–2025

Across 285 payments — averaging $234.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$41K
  • Medical Device Business Services, Inc.$13K
  • Ethicon Endo-surgery Inc.$6K
  • Intuitive Surgical$3K
  • AbbVie$2K
  • Bristol Myers Squibb$476
  • plus $2K from 27 others

What the payments were for

  • Consulting fees$53,44680%
  • Travel & lodging$7,48911%
  • Food & beverage$5,9419%
  • Education$500%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,934 in reported general payments places this provider in the 95th percentile of 54 colon & rectal surgery providers in Indiana.

See all colon & rectal surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$92,038
Medicare patients
274
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine11$3,765
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl28$403
Promethazine Hcl176$199
Neomycin Sulfate24$133
Tramadol Hcl20$57
Metronidazole31$52

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →